Concepedia

Edna Nyangau

EN

15

Publications

1.3K

Citations

12

H-Index

2016

Active since

Affiliations

University of California, Berkeley(Current)

University of California San Diego

Duke Medical Center

Duke University

KineMed (United States)

Edna Nyangau is an author at University of California, Berkeley specializing in health sciences, nonalcoholic fatty liver disease, and pathology.

ORCID

Top concepts

Publications per year

2016–2023

15

Publications

15

Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease

Gordon I. Smith, Mahalakshmi Shankaran, Mihoko Yoshino et al. · Journal of Clinical Investigation · 2019 · 669 citations · Full text

, , +22

Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis

Eric Lawitz, Angie Coste, Fred Poordad et al. · Clinical Gastroenterology and Hepatology · 2018 · 213 citations

, , +12

Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood

Martin Decaris, Kelvin W. Li, Claire Emson et al. · Hepatology · 2016 · 96 citations · Full text

Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease

Catherine C. Cohen, Kelvin W. Li, Adina Alazraki et al. · Journal of Clinical Investigation · 2021 · 76 citations · Full text

LRH-1 regulates hepatic lipid homeostasis and maintains arachidonoyl phospholipid pools critical for phospholipid diversity

Diego A. Miranda, William C. Krause, Amaury Cazenave‐Gassiot et al. · JCI Insight · 2018 · 53 citations · Full text

Rows per page

1–5 of 15